Abstract
In this chapter, recommendations for prescribing, recording and especially reporting of dose in BNCT are developed and discussed. The main goal of the authors was that these recommendations are coherent with the general rules of prescribing, recording and reporting of dose in conventional radiotherapy following international standards. The fundamental quantity used in all therapeutic applications of ionising radiation is the absorbed dose (D) with its unit gray (Gy). The complex dose distribution in tissue resulting from BNCT, which basically is due to 4 different dose components with different LET, different RBE and different spatial distribution, needs a sophisticated and detailed reporting system in order to avoid any risk of confusion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
BIPM (2006) Bureau International des Poids et Mesures: the international system of units (SI), 8th edn. BIPM, Sèvres
Gabel D, Philipp KHI, Wheeler FJ, Huiskamp R (1998) The compound factor of the 10B(n,α)7Li reaction from borocaptate sodium and the relative biological effectiveness of recoil protons for induction of brain damage in Boron Neutron Capture Therapy. Radiat Res 149:378–386
Rassow J, Sauerwein W, Wittig A, Bourhis-Martin E, Hideghéty K, Moss R (2004) Advantage and limitations of weighting factors and weighted dose quantities and their units in Boron Neutron Capture Therapy. Med Phys 31:1128–1134
Busse PM, Zamenhof RG, Harling OK, Kaplan I, Kaplan J, Chuang CF, Goorley JT, Kiger WS III, Riley KJ, Tang L, Solares GR, Palmer MR (2001) The Harvard-MIT BNCT program – overview of the clinical trials and translational research. In: Hawthorne MF, Shelley K, Wiersema RJ (eds) Frontiers in neutron capture therapy, vol 1. Kluwer Academic/Plenum Press, New York, Boston, Dordrecht, London, Moscow, pp 37–60
Diaz AZ, Chanana AD, Capala J, Chadha M, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Ma R, Pendzick N, Peress NS, Wielopolski L (2001) Boron Neutron Capture Therapy for glioblastoma multiforme. Results from the initial phase I/II dose escalation studies. In: Frontiers in neutron capture therapy, vol 1. Kluwer Academic/Plenum Publishers, New York, pp 61–72
Färkkilä M, Aschan C, Auterinen I, Benczik J, Hüsmäki P, Jääskelainen J, Järviluoma E, Joensuu H, Kallio M, Kankaanranta L, Kortesniemi M, Kosunen A, Kotiluoto P, Kulvik M, Laakso J, Pakkala S, Rasilainen M, Salmenhaara S, Savolainen S, Seppälä T, Serén T, Snellman M, Suominen M, Tenhunen M, Toivonen M, Tähtinen L, Vähätalo J (2001) At the threshold of clinical trials. The status of the Finnish BNCT project. Front Neutron Capture Ther 1:129–131
Sauerwein W, Rassow J, Mijnheer BJ (1997) Considerations about specification and reporting of dose in BNCT. In: Larsson B, Crawford J, Weinreich R (eds) Advances in neutron therapy, vol II, Chemistry and biology. Elsevier, Amsterdam, pp 531–534
Kiger WS III, Palmer MR, Riley KJ, Zamenhof RG, Busse PM (2002) Pharmacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy. 10B concentration predictions and dosimetric consequences. In: Sauerwein W, Moss R, Wittig A (eds) Research and development neutron capture therapy. Monduzi Editore, International Proceedings Division, Bologna, pp 985–992
Wittig A, Hideghéty K, Paquis P, Heimans J, Vos M, Goetz C, Haselsberger K, Grochulla F, Moss R, Morrissey J, Bourhis-Martin E, Rassow J, Stecher-Rasmussen F, Turowski B, Wiestler M, de Vries MJ, Fankhauser H, Gabel D, Sauerwein W (2002) Current clinical results of the EORTC-study 11961. In: Sauerwein W, Moss R, Wittig A (eds) Research and development neutron capture therapy. Monduzi Editore, International Proceedings Division, Bologna, pp 1117–1122
Wambersie A, Gahbauer RA, Whitmore G, Levin CV (2001) Dose and volume specification for reporting NCT: an ICRU-IAEA initiative. Current status of neutron capture therapy (International Atomic Energy Agency Report No. IAEA-TECDOC-1223, 2001), pp 9–10
Gahbauer RA, Gupta N, Blue T, Carpenter D, Sauerwein W, Wambersie A (2001) Reporting a BNCT irradiation. Application of the ICRU recommendations to the specific situation in BNCT. In: Hawthorne MF, Shelley K, Wiersema RJ (eds) Frontiers in neutron capture therapy, vol 1. Kluwer Academic/Plenum Press, New York, Boston, Dordrecht, London, Moscow, pp 561–569
International Commission on Radiation Units and Measurements (2007) Prescribing, recording, and reporting proton-beam therapy (ICRU report 78). J ICRU 7(2):27, ISSN 1473-6691
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rassow, J., Sauerwein, W.A.G. (2012). Prescribing, Recording and Reporting of BNCT. In: Sauerwein, W., Wittig, A., Moss, R., Nakagawa, Y. (eds) Neutron Capture Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31334-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-31334-9_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31333-2
Online ISBN: 978-3-642-31334-9
eBook Packages: MedicineMedicine (R0)